1-12 of 12
Sirkku Jyrkkiö
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Joint Analyses of Serum Proteins and Circulating Tumor DNA Improves Risk Assessment and Subtype Stratification in Large B-Cell Lymphomas

Maare Arffman, Leo Meriranta, Judit Mészáros Jørgensen, Harald Holte, Øystein Fluge, Peter de Nully Brown, Kristina Drott, Sirkku Jyrkkiö, Suvi-Katri Leivonen, Sirpa Leppä
Journal: Blood
Blood (2023) 142 (Supplement 1): 3015.
https://doi.org/10.1182/blood-2023-177849
Published: 2023
Journal Articles

Distinct Genetic and Fragmentomic Signatures of Plasma Ctdna Synergize and Resolve Clinical Challenges in Patients with Large B-Cell Lymphoma

Leo Meriranta, Maare Arffman, Judit Mészáros Jørgensen, Harald Holte, Kristina Drott, Henrikki Almusa, Emma Saarinen, Sari Hannula, Marja-Liisa Karjalainen-Lindsberg, Klaus Beiske, Mette Ølgod Pedersen, Øystein Fluge, Peter de Nully Brown, Sirkku Jyrkkiö, Sirpa Leppä
Journal: Blood
Blood (2023) 142 (Supplement 1): 1625.
https://doi.org/10.1182/blood-2023-188493
Published: 2023
Journal Articles

Biomarker-Driven Treatment Strategy in High-Risk Large B-Cell Lymphoma: Final Results of a Nordic Phase 2 Study

Sirpa Leppa, Judit M. Jørgensen, Marja-Liisa Karjalainen-Lindsberg, Klaus Beiske, Mette Pedersen, Kristina Drott, Annika Pasanen, Kristiina Karihtala, Susanna Mannisto, Leo Meriranta, Bente Wold, Marianne Brodtkorb, Unn Merete Fagerli, Thomas S. Larsen, Lars Munksgaard, Kaisa Sunela, Øystein Fluge, Sirkku Jyrkkio, Peter de Nully Brown, Harald Holte
Journal: Blood
Blood (2022) 140 (Supplement 1): 1768–1769.
https://doi.org/10.1182/blood-2022-158183
Published: 2022
Journal Articles

Serum Proteome Profiling Reveals Inflammatory, Molecular and Prognostic Information Beyond the Ctdna in Aggressive B-Cell Lymphomas

Maare Arffman, Leo Meriranta, Harald Holte, Judit Jørgensen, Peter De Nully Brown, Sirkku Jyrkkio, Mats Jerkeman, Øystein Fluge, Magnus Björkholm, Matias Autio, Suvi-Katri Leivonen, Sirpa Leppa
Journal: Blood
Blood (2022) 140 (Supplement 1): 1316–1317.
https://doi.org/10.1182/blood-2022-158426
Published: 2022
Journal Articles

Survival, Transformation and Causes of Death of Follicular Lymphoma: A Finnish Nationwide Population-Based Study

Ilja Kalashnikov, Tomas Tanskanen, Leevi Viisanen, Nea Malila, Sirkku Jyrkkio, Sirpa Leppä
Journal: Blood
Blood (2022) 140 (Supplement 1): 9345–9346.
https://doi.org/10.1182/blood-2022-170380
Published: 2022
Journal Articles

Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma

Leo Meriranta, Amjad Alkodsi, Annika Pasanen, Maija Lepistö, Parisa Mapar, Yngvild Nuvin Blaker, Judit Jørgensen, Marja-Liisa Karjalainen-Lindsberg, Idun Fiskvik, Lars Tore G. Mikalsen, Matias Autio, Magnus Björkholm, Mats Jerkeman, Øystein Fluge, Peter Brown, Sirkku Jyrkkiö, Harald Holte, Esa Pitkänen, Pekka Ellonen, Sirpa Leppä
Journal: Blood
Blood (2022) 139 (12): 1863–1877.
https://doi.org/10.1182/blood.2021012852
Published: 2022
Includes: Supplemental data
Journal Articles

Survival and Transformation of Marginal Zone Lymphoma: A Finnish Nationwide Population-Based Study

Ilja Kalashnikov, Tomas Tanskanen, Leevi Viisanen, Nea Malila, Sirkku Jyrkkio, Sirpa Leppa
Journal: Blood
Blood (2021) 138 (Supplement 1): 4517.
https://doi.org/10.1182/blood-2021-149764
Published: 2021
Journal Articles

Outcome of Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Finnish Nationwide Population-Based Study

Ilja Kalashnikov, MD, Nea Malila, MD PhD, Sirkku Jyrkkio, MD PhD, Sirpa Leppa, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 16–17.
https://doi.org/10.1182/blood-2020-139913
Published: 2020
Journal Articles

Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis for High-Risk DLBCL. -Final Analysis from a Nordic Phase II Study (the CHIC trial)

Sirpa Leppa, MD, Judit Joergensen, Anne Tierens, Ingunn Østlie, Unn Merete Fagerli, Peter de Nully Brown, MD, Thomas S Larsen, Susanna Mannisto, Lars Munksgaard, Martin Maisenhölder, Kaija Vasala, Peter Meyer, Mats Jerkeman, Magnus Bjorkholm, Oystein Fluge, Sirkku Jyrkkio, Elisabeth Ralfkiaer, Signe Spetalen, Marja-Liisa Karjalainen-Lindsberg, Harald Holte
Journal: Blood
Blood (2016) 128 (22): 1854.
https://doi.org/10.1182/blood.V128.22.1854.1854
Published: 2016
Journal Articles

Rituximab Maintenance Bimonthly for Two Years after Prolonged Immunochemotherapy in Elderly Patients with Mantle Cell Lymphoma (MCL) Results in Long Remissions: Update with Six-Year Follow-up of a Prospective Study By the Finnish Lymphoma Group

Riikka Räty, Tuomo Honkanen, Esa Jantunen, MDPhD, Sirkku Jyrkkiö, Marja-Liisa Karjalainen-Lindsberg, MD PhD, Outi Kuittinen, Minna Lehto, Maija Mikkola, Eira Poikonen, Auvo Rauhala, Johanna Rimpiläinen, Anu Räsänen, MD, Sanna Siitonen, Merja Suominen, MD, Mirja Vapaatalo, Erkki Elonen
Journal: Blood
Blood (2014) 124 (21): 1749.
https://doi.org/10.1182/blood.V124.21.1749.1749
Published: 2014
Journal Articles

Dose-Dense Chemoimmunotherapy and Early Central Nervous System Prophylaxis For High-Risk Diffuse Large B-Cell Lymphoma. –Preliminary Results From a Nordic Phase II Study

Sirpa Leppa, Anne Maria Tierens, Judit Jorgensen, Mats Jerkeman, Magnus Bjorkholm, PhD, Øystein Fluge, Sirkku Jyrkkio, Harald Holte, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 849.
https://doi.org/10.1182/blood.V122.21.849.849
Published: 2013
Journal Articles

R-CHOEP-14 X 6 Followed by Systemic CNS Prophylaxis for Diffuse Large B-Cell Lymphoma (DLBCL)/Follicular Lymphoma (FL) Grade 3 with Age Adjusted IPI Score 2–3: Preliminary Results of a Nordic Lymphoma Group (NLG) Phase 2 Study Including 160 Patients Aged 18- 64 Years

Harald Holte, MD, PhD, Sirpa M. Leppa, MD, PhD, Magnus Bjorkholm, MD, PhD, Oystein Fluge, MD, PhD, Sirkku Jyrkkio, MD, PhD, Jan Delabie, MD, PhD, Christer Sundstrom, MD, PhD, Marja-Liisa Karjalainen-Lindsberg, MD, PhD, Martin Erlanson, MD, PhD, Arne Kolstad, MD, PhD, Alexander Fossa, MD, PhD, Björn Östenstad, MD, PhD, Eva Lofvenberg, MD, PhD, Marie Nordström, MD, PhD, Lars Möller-Pedersen, MD, PhD, Harald Anderson, PhD, Mats Jerkeman, MD, PhD, Mikael Eriksson, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 3604.
https://doi.org/10.1182/blood.V112.11.3604.3604
Published: 2008